Stem cell therapy (aHSCT and MSC): MS Clinical Trials
5 active trials · 3 recruiting
5 active multiple sclerosis clinical trials involve Stem cell therapy (aHSCT and MSC), 3 currently recruiting. The list is matched on the interventions registered at ClinicalTrials.gov, so it includes head-to-head comparisons and studies where this therapy is the comparator as well as the treatment under test.
Trial results are not treatment advice: whether a therapy is right for you depends on your type of MS, disease activity and history, which is a conversation for your neurologist.
Active Stem cell therapy (aHSCT and MSC) MS trials
RecruitingPhase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Autologous Hematopoietic Stem Cell Tr… · Best Available Therapy (BAT)
15 states156 participantsDetails ›
RecruitingPhase 1
Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis
Sponsor: Rennes University Hospital
Adipose tissue-derived Mesenchymal St…
10 participantsDetails ›
RecruitingPhase 1
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
Sponsor: Ever Supreme Bio Technology Co., Ltd.
Allogeneic umbilical cord mesenchymal… · Control group
41 participantsDetails ›
Closed to new patientsPhase 2
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
Sponsor: Fred Hutchinson Cancer Center
Anti-Thymocyte Globulin · Autologous Hematopoietic Stem Cell Tr…
2 states53 participantsDetails ›
Closed to new patientsPhase 2
HB-adMSCs for the Treatment of Patients With Multiple Sclerosis
Sponsor: Hope Biosciences Research Foundation
Autologous HB-adMSCs
1 state10 participantsDetails ›
MS trials by therapy
Exercise and rehabilitation (81)Ocrelizumab (Ocrevus) (34)Ofatumumab (Kesimpta) (18)Diet and nutrition (12)Teriflunomide (Aubagio) (9)Fingolimod (Gilenya) (8)Ublituximab (Briumvi) (7)Cladribine (Mavenclad) (7)Rituximab (6)Ozanimod (Zeposia) (6)Dimethyl fumarate (Tecfidera) (6)Interferon beta (5)Fenebrutinib (5)Natalizumab (Tysabri) (4)Siponimod (Mayzent) (4)Remibrutinib (4)CAR-T cell therapy (4)Alemtuzumab (Lemtrada) (3)Glatiramer acetate (Copaxone) (3)Frexalimab (3)Metformin (3)Cannabis and cannabinoids (3)
